Empagliflozin INN & Linagliptin INN
Composition: Emparol-L 10/5 Tablet : Each film coated tablet contains Empagliflozin INN 10mg & Linagliptin INN 5mg.
Emparol-L 25/5 Tablet : Each film coated tablet contains Empagliflozin INN 25mg & Linagliptin INN 5mg.
Indications :
Emparol-L is indicated: * As an adjunct to diet and exercise to improve glycemic
control in adults with type 2 diabetes mellitus to reduce the risk of
cardiovascular death in adults with type 2 diabetes mellitus and established cardiovascular
disease.
Dosage
& Administration : The recommebded dose is Empagliflozin 10 mg / Linagliptin
5 mg (Emparol-L 10/5) once daily, taken in the morning, with or without food.
Dose may be increased to Empagliflozin 25 mg / Linagliptin 5 mg (Emparol-L
10/5) once daily. Or, as directed by the registered physician.
Use in pregnancy and lactation :Pregnancy:Empagliflozin or Empagliflozin &
Linaglipin combionation is not recommended during the second and third trimesters of pregnancy. The limited available data in pregnant woman are not sufficient to determine a drug-associated risk for amjor birth defects and miscarriage. There are risks to the mother and fetus associated with poorly controlled diabetes
in pregnancy.
Lactation: There is no information regarding the presence of Empagliflozin&Linagliptin,
or its individual components in human milk, the effects on the breastfed infant,
or the effects on milk production. Use is recommended while breastfeeding.
Packing : Emparol-L 10/5 Tablet : Each box contains 14’s Tablets in blister pack.
Emparol-L 25/5 Tablet : Each box contains 14’s Tablets in blister pack.
